AstraZeneca
AZN
#52
Rank
C$397.27 B
Marketcap
C$256.16
Share price
-1.93%
Change (1 day)
4.55%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): C$9.98

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is C$10.20. In 2024 the company made an earnings per share (EPS) of C$6.51 an increase over its 2023 EPS that were of C$5.50.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$9.98
2024C$6.5118.23%
2023C$5.5081.13%
2022C$3.04631.03%
2021C$0.42-88.11%
2020C$3.50136.89%
2019C$1.48-39.41%
2018C$2.44-28.27%
2017C$3.40-14.37%
2016C$3.9724.11%
2015C$3.20127.55%
2014C$1.40-51.96%
2013C$2.92-58.95%
2012C$7.12-32.2%
2011C$10.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57-6.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.52-26.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.02-90.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$3.87-62.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.27 333.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.84-72.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$3.38-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.48-36.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.12-59.59%๐Ÿ‡ฌ๐Ÿ‡ง UK